Lot B5624 is one of 8 lots of Tirzepatide we have release-tested for this catalog, scored on purity, quantity, and batch traceability. Independent third-party HPLC/MS verification of this lot is available on request.
9.8/10
A+ Excellent
Purity
3.8 / 4
Quantity
4.0 / 4
Identifier
2.0 / 2
The test score is calculated from purity (how much of the vial content is the expected compound, with values closest to 100% best and below 98% considered unacceptable), quantity (how close the measured amount is to the label claim, more than plus or minus 20% is unacceptable), and identifier (whether the batch this vial came from can be traced to a certificate).
Sample details
ProductTirzepatide 10mg
Sample typeSealed retail vial
Date received14 Nov 2025
Physical detailsPrinted label / aluminum crimp / amber cap
Test details
MethodRP-HPLC-UV + LC-MS
Tested on16 Nov 2025
Tested byRTT Peptides QC
ReportQC-20338
Score breakdown
Purity
99.63%
3.8 / 4
Measured purity by RP-HPLC-UV against the ≥ 98.0% release specification. Net peptide content 89.0%.
Quantity
9.8mg
4.0 / 4
Label claim 10mg, measured 9.8mg, divergence -2.0%. Within plus or minus 5% of label scores full marks.
Identifier
B5624
2.0 / 2
Batch identifier printed on the vial and traceable to this certificate, so the lot can be verified end to end.
Analytical release certificate · RP-HPLC-UV with LC-MS confirmation Independent third-party verification available on request.
ReportQC-20338Issued2025-11-17Page1 of 1
Certificate of AnalysisTirzepatide · Lot B5624
SampleTirzepatide
Issued forRTT Peptides
Lot / BatchB5624
Label claim10mg
CAS2023788-19-2
AppearanceWhite lyophilized powder
Date received2025-11-14
Date analyzed2025-11-16
01 Purity by RP-HPLC-UV
Figure 1 · Reverse-phase HPLC-UV chromatogram at 214 nm. C18, 2.7 µm; gradient 0.1% TFA in water / acetonitrile at 1.0 mL/min.
Purity by RP-HPLC-UV: component retention time, peak area, and area percent
#
Component
RT (min)
Area (mAU·s)
Area %
1
RRT 0.16
1.60
5.9
0.14
2
RRT 0.37
3.79
5.0
0.12
3
Tirzepatide ▸ main
10.14
4184.5
99.63
4
RRT 1.04
10.52
4.6
0.11
✓
Purity (HPLC) 99.63% · net peptide content 89.0% · meets the ≥ 98.0% release specification.
02 Identity by LC-MS
Expected average mass4813.45 Da
Observed mass4813.50 Da
✓
Identity confirmed · observed mass conforms to the expected structure of Tirzepatide.
03 Summary of results
Summary of results: test, method, specification, result, and outcome
Test
Method
Specification
Result
Outcome
Purity
RP-HPLC-UV, 214 nm
≥ 98.0 %
99.63 %
✓ Pass
Identity
LC-MS (ESI+)
Consistent with structure
Confirmed
✓ Pass
Net peptide content
By difference
Report
89.0 %
n/a
Appearance
Visual
White lyophilized powder
Conforms
✓ Pass
Reconstitution
Bacteriostatic water
Clear, particulate-free
Conforms
✓ Pass
The submitted lot conforms to identity and meets the stated purity specification. Analysis was performed by RP-HPLC-UV with LC-MS confirmation. Results relate only to the lot as received and tested and do not constitute a certificate of any third party.
Quality Assurance · RTT Peptides
Issued under the RTT Peptides quality program; this is the vendor's own release certificate. Independent third-party HPLC/MS verification of any lot is available on request. Products are supplied strictly as research reagents for in-vitro laboratory use only, not for human or animal consumption. Report QC-20338 · RP.
This is the vendor's own release certificate. Independent third-party HPLC/MS verification of this lot is available on request.
Research use only
RTT Peptides sells laboratory research reagents. They are not for human or animal consumption. Please confirm the statements below to place your order.
